Synthetic Biology: The Real Thing



Boston —At last month's sold-out First International Meeting on Synthetic Biology* at MIT, engineers and researchers discussed exciting progress in creating a "library" of biological parts that can be combined in novel ways to create new machines.

"Think Legos," said Thomas Knight, a researcher at MIT's laboratory for artificial intelligence and the department of electrical engineering and computer science. Knight is a key player in efforts to build a library of "BioBricks" comprising the MIT Registry of Standard Biological Parts (parts.mit.edu). BioBricks are functional pathways — not just DNA segments — and typically code for operators, protein-coding regions, and transcriptional terminators. Some of the parts have been combined into logic gates.

Currently there are about 100 BioBricks, which are combined into "full circuits" in plasmids and expressed (usually in Escherichia coli) using traditional microbiology techniques.

Knight argued that synthetic biology requires an approach fundamentally different than traditional biology. His can-do attitude was evident in new studies designed "to engineer a simpler chassis and power supply" by stripping out redundant genes from the genome of bacterium Mesoplasma florum.

*First International Meeting on Synthetic Biology; MIT, June 10-12.
This work to create a "reduced" or minimal genome that provides room to insert desirable genes by deleting unnecessary ones builds on studies in 1999 conducted by J. Craig Venter and colleagues from The Institute for Genomic Research, which showed that no more than 350 protein-coding genes of the bacterium Mycoplasma genitalium are required to sustain life.

Fred Blattner, a pioneer in E. coli sequencing from the University of Wisconsin, good-naturedly jabbed at Knight. "This is fascinating, though, if I might say, a little overly enthusiastic," Blattner said. "We're going in the same line ... in attempting to get simplicity, but we're also trying to use an engineering principle of practicality."

Starting with the K12 strain of E. coli, Blattner has engineered several "multiple deletion strains" (MDS). His approach retains core genes required for growth on minimal media, while removing intervening sequences and "potential virulence genes, adherence genes, toxic genes, cryptic operons, and to do it all without leaving any remnants."

The current focus of Blatt-ner's work is strain MDS72, which will have roughly 20 percent less "stuff" in its genome. "3,700 genes is what nature is telling us you need to be a good E. coli," Blattner said, adding that since many of the deletions represent islands of pathogenicity, the stripped-down E. coli will also be safer to use.




Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .